SurModics (SRDX) Tops Q1 EPS by 10c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. OPCH
5. BBIO
6. NVDA
7. GOOGL
8. CHRW
9. AMD
10. RXO

Go back to SurModics (SRDX) Tops Q1 EPS by 10c; Raises Outlook

Surmodics Reports First Quarter Fiscal 2017 Results

February 2, 2017 7:30 AM EST

GAAP Revenue of $17.8 Million, up 7%; Medical Device increase 12% GAAP EPS of $0.17, Non-GAAP EPS of $0.19 Raises Revenue and EPS Guidance

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2017 first quarter, ended December 31, 2016.

The Surmodics team made meaningful investments in our whole-product strategy while delivering top-line growth in the first quarter of fiscal... More